Skip to main content
MICRO-X LIMITED logo

MICRO-X LIMITED — Investor Relations & Filings

Ticker · MX1 ISIN · AU000000MX15 ASX Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2017-03-21 Investor Presentation
Country AU Australia
Listing ASX MX1

About MICRO-X LIMITED

https://www.micro-x.com

Micro-X Limited specializes in the development and commercialization of innovative X-ray products utilizing proprietary carbon nanotube (CNT) cold cathode technology. This technology enables the miniaturization of X-ray sources, allowing for the creation of lightweight, portable, and highly efficient imaging systems. The company's product portfolio includes the Nano and Rover mobile medical X-ray units designed for bedside and field hospital use, and the Argus X-ray camera for high-resolution security and counter-IED applications. Micro-X is also developing advanced solutions for airport security through self-service checkpoints and portable head CT scanners for rapid stroke diagnosis in pre-hospital environments. By replacing traditional, bulky thermionic X-ray tubes with electronic CNT emitters, the company provides enhanced mobility and digital precision across medical, defense, and security markets.

Recent filings

Filing Released Lang Actions
Investor Presentation 7 pages 1.9MB
Investor Presentation Classification · 90% confidence The document is titled 'Investor Update' and dated March 2017. It contains information about company quality accreditation, regulatory approvals, reliability testing, market interest, and pathway to launch. The content is a detailed update on company progress and operational milestones rather than a formal financial report or regulatory filing. The document length is 3108 characters, which is relatively short and does not contain financial statements or detailed financial analysis. It is not an earnings release, annual report, or interim report. It is also not a formal regulatory filing or certification. The document is best classified as an Investor Presentation (IP) because it provides detailed information aimed at investors about company progress, regulatory status, and market development, consistent with the description of an investor presentation focusing on financials, strategy, and market position.
2017-03-21 English
Nano Commercialisation Update - K number received from FDA 1
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated March 15, 2017, from Micro-X Limited. It discusses the receipt of a 'K' number from the FDA for a medical device, updates on regulatory submissions, and testing program progress. The content is an update on regulatory and commercial progress rather than a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. The document length is short (2457 characters) and is clearly an announcement of a regulatory milestone and commercial update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-03-14 English
Nano Commercialisation Update - ISO 13485 Accreditation 1
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated March 6, 2017, from Micro-X Limited. It provides an update on the company's ISO 13485 accreditation status and recent marketing activities for a product. The content is a corporate update about a certification milestone and product marketing, not a financial report, regulatory filing, or management change. The document length is short (2042 characters) and does not contain financial statements or detailed financial data. It is an announcement of a commercialisation update and accreditation status, which does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement or certification letter. The best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories.
2017-03-05 English
Appendix 4D and Half Year Financial Report 19 pages 1.7MB
Regulatory Filings
2017-02-27 English
Quarterly Cash Flow & Business Update 8 pages 369.6KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement titled 'QUARTERLY CASH FLOW & BUSINESS UPDATE' for Micro-X Limited, dated 31 January 2017, covering the quarter ended 31 December 2016. It includes detailed financial data such as cash flow statements, cash receipts, payments, and financing activities. The document references Appendix 4C, which is a quarterly report required under ASX Listing Rule 4.7B. The content includes substantive financial data and analysis for a period shorter than a full fiscal year (quarterly). It is not merely an announcement of a report but contains the actual financial statements and business update. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q2 2016
2017-01-30 English
Change of Director's Interest Notice 3 pages 381.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including the number of shares and options held before and after the change, the nature of the change, and dates. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It does not contain financial statements, earnings data, or management commentary. Therefore, it fits the definition of 'Director's Dealing' filings.
2017-01-05 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.